what is glp-1 drug Glucagon-like peptide-1 GLP-1 Medications for Weight Loss:

[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Shan C., et al

[92] [93] Brazil [edit] In Brazil, the supreme court refused to extend semaglutide's patent protection, which expired in March 2026

This distinction matters in the GLP-1 market, as regulatory scrutiny, quality controls, and allowable production practices vary significantly between the two models and, as of April 2026, the two tiers face meaningfully different enforcement exposure

Tirzepatide, like semaglutide, is a large peptide unlikely to transfer significantly into breast milk based on theoretical pharmacokinetic properties, but formal lactation studies have not been conducted

Obesity treatment with bariatric surgery vs GLP-1 receptor agonists

This is pressuring manufacturers to refine marketing language, substantiation practices, and product-positioning strategies across digital wellness channels